| Year |
Citation |
Score |
| 2018 |
Lee SJ, Li X, Huang H, Zelen M. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 44S-53S. PMID 29554465 DOI: 10.1177/0272989X17741634 |
0.321 |
|
| 2011 |
Mandelblatt JS, Cronin KA, Berry DA, Chang Y, de Koning HJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, van Ravesteyn NT, Zelen M, Feuer EJ. Modeling the impact of population screening on breast cancer mortality in the United States. Breast (Edinburgh, Scotland). 20: S75-81. PMID 22015298 DOI: 10.1016/S0960-9776(11)70299-5 |
0.313 |
|
| 2011 |
Mandelblatt J, Cronin K, Berry D, Feuer E, de Koning H, Lee S, Plevritis S, Schechter C, Stout N, van Ravesteyn N, Zelen M. S20 Changing the guidelines for breast cancer screening: modeling mammography benefits and harms The Breast. 20: S7-S8. DOI: 10.1016/S0960-9776(11)70023-6 |
0.333 |
|
| 2010 |
Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway New England Journal of Medicine. 363: 1203-1210. PMID 20860502 DOI: 10.1056/Nejmoa1000727 |
0.335 |
|
| 2010 |
Zheng L, Zelen M. Randomized clinical trials Wiley Interdisciplinary Reviews: Computational Statistics. 2: 49-53. DOI: 10.1002/Wics.63 |
0.329 |
|
| 2009 |
Mandelblatt JS, Cronin KA, Bailey S, Berry DA, Koning HJd, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, ... ... Zelen M, et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms Annals of Internal Medicine. 151: 738-747. DOI: 10.1059/0003-4819-151-10-200911170-00010 |
0.344 |
|
| 2008 |
Lee SJ, Zelen M. Mortality modeling of early detection programs Biometrics. 64: 386-395. PMID 17725809 DOI: 10.1111/J.1541-0420.2007.00893.X |
0.309 |
|
| 2008 |
Zheng L, Zelen M. Multi-center clinical trials: Randomization and ancillary statistics Annals of Applied Statistics. 2: 582-600. DOI: 10.1214/07-Aoas151 |
0.349 |
|
| 2006 |
Lee S, Zelen M. A stochastic model for predicting the mortality of breast cancer Journal of the National Cancer Institute. Monographs. 79-86. PMID 17032897 DOI: 10.1093/Jncimonographs/Lgj011 |
0.362 |
|
| 2005 |
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. The New England Journal of Medicine. 353: 1784-92. PMID 16251534 DOI: 10.1056/Nejmoa050518 |
0.332 |
|
| 2005 |
Shen Y, Zelen M. Robust modeling in screening studies: Estimation of sensitivity and preclinical sojourn time distribution Biostatistics. 6: 604-614. PMID 15860542 DOI: 10.1093/Biostatistics/Kxi030 |
0.353 |
|
| 2004 |
Hu P, Zelen M. Planning of randomized early detection trials Statistical Methods in Medical Research. 13: 491-506. PMID 15587435 DOI: 10.1191/0962280204Sm379Ra |
0.34 |
|
| 2004 |
Lee S, Huang H, Zelen M. Early detection of disease and scheduling of screening examinations Statistical Methods in Medical Research. 13: 443-456. PMID 15587433 DOI: 10.1191/0962280204Sm377Ra |
0.352 |
|
| 2004 |
Davidov O, Zelen M. Overdiagnosis in early detection programs Biostatistics. 5: 603-613. PMID 15475422 DOI: 10.1093/Biostatistics/Kxh012 |
0.326 |
|
| 2003 |
Hu P, Zelen M. Experimental design issues for the early detection of disease: novel designs. Biostatistics (Oxford, England). 3: 299-313. PMID 12933599 DOI: 10.1093/Biostatistics/3.3.299 |
0.364 |
|
| 2003 |
Lee SJ, Zelen M. Modelling the early detection of breast cancer Annals of Oncology. 14: 1199-1202. PMID 12881377 DOI: 10.1093/Annonc/Mdg323 |
0.4 |
|
| 2002 |
Lee SJ, Zelen M. Statistical models for screening: planning public health programs Cancer Treatment and Research. 113: 19-36. PMID 12613348 DOI: 10.1007/978-1-4757-3571-0_2 |
0.329 |
|
| 2002 |
Parmigiani G, Skates S, Zelen M. Modeling and optimization in early detection programs with a single exam Biometrics. 58: 30-36. PMID 11890325 DOI: 10.1111/J.0006-341X.2002.00030.X |
0.311 |
|
| 2001 |
Shen Y, Wu D, Zelen M. Testing the independence of two diagnostic tests Biometrics. 57: 1009-1017. PMID 11764239 DOI: 10.1111/J.0006-341X.2001.01009.X |
0.377 |
|
| 2001 |
Shen Y, Zelen M. Screening sensitivity and sojourn time from breast cancer early detection clinical trials: Mammograms and physical examinations Journal of Clinical Oncology. 19: 3490-3499. PMID 11481355 DOI: 10.1200/Jco.2001.19.15.3490 |
0.386 |
|
| 2001 |
Nam CM, Zelen M. Comparing the Survival of Two Groups with an Intermediate Clinical Event Lifetime Data Analysis. 7: 5-19. PMID 11280847 DOI: 10.1023/A:1009609925212 |
0.342 |
|
| 2000 |
Davidov O, Zelen M. Designing cancer prevention trials: A stochastic model approach Statistics in Medicine. 19: 1983-1995. PMID 10900447 DOI: 10.1002/1097-0258(20000815)19:15<1983::Aid-Sim534>3.0.Co;2-E |
0.377 |
|
| 2000 |
Lee SJ, Zelen M. Clinical Trials and Sample Size Considerations: Another Perspective Statistical Science. 15: 95-110. DOI: 10.1214/Ss/1009212752 |
0.33 |
|
| 1999 |
Shen YU, Zelen M. Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding Biometrika. 86: 503-515. DOI: 10.1093/Biomet/86.3.503 |
0.324 |
|
| 1998 |
Wallace BC, Zelen M, Zani Pacheco CL. Milk leakage in nonlactating women: A randomized clinical trial evaluating a polyvinyl chloride device versus disposable breast pads Journal of Women's Health. 7: 1283-1288. PMID 9929861 DOI: 10.1089/Jwh.1998.7.1283 |
0.307 |
|
| 1998 |
Lee SJ, Zelen M. Scheduling periodic examinations for the early detection of disease: Applications to breast cancer Journal of the American Statistical Association. 93: 1271-1281. DOI: 10.1080/01621459.1998.10473788 |
0.331 |
|
| 1997 |
Ping HU, Zelen M. Planning clinical trials to evaluate early detection programmes Biometrika. 84: 817-829. DOI: 10.1093/Biomet/84.4.817 |
0.369 |
|
| 1990 |
Zelen M. Randomized consent designs for clinical trials: An update Statistics in Medicine. 9: 645-656. PMID 2218168 DOI: 10.1002/Sim.4780090611 |
0.334 |
|
| 1989 |
Day R, Ware JH, Wartenberg D, Zelen M. An investigation of a reported cancer cluster in randolph, Massachusetts Journal of Clinical Epidemiology. 42: 137-150. PMID 2918323 DOI: 10.1016/0895-4356(89)90087-5 |
0.308 |
|
| 1988 |
Zelen M. Statistical issues in the planning of prevention studies Cancer Investigation. 6: 615-620. PMID 3214765 DOI: 10.3109/07357908809082129 |
0.311 |
|
| 1988 |
Zelen M. Are primary cancer prevention trials feasible? Journal of the National Cancer Institute. 80: 1442-1444. PMID 3054126 DOI: 10.1093/Jnci/80.18.1442 |
0.337 |
|
| 1988 |
Greenspan E, Jordan C, Meyskens F, Norton L, Osborne CK, Nixon D, Powles T, Tormey D, Zelen M. Chemoprevention breast cancer workshop, november 20, 1987 panel discussions Cancer Investigation. 6: 663-667. DOI: 10.3109/07357908809082138 |
0.315 |
|
| 1987 |
Begg CB, Pocock SJ, Freedman L, Zelen M. State of the art in comparative cancer clinical trials Cancer. 60: 2811-2815. PMID 3315175 DOI: 10.1002/1097-0142(19871201)60:11<2811::Aid-Cncr2820601136>3.0.Co;2-P |
0.381 |
|
| 1984 |
Feldstein M, Zelen M. Inferring the natural time history of breast cancer: implications for tumor growth rate and early detection. Breast Cancer Research and Treatment. 4: 3-10. PMID 6697009 DOI: 10.1007/Bf01806982 |
0.348 |
|
| 1983 |
Zelen M. Innovations in the design of clinical trials in breast cancer Breast Cancer Research and Treatment. 3: 137-142. PMID 6616074 DOI: 10.1007/Bf01803556 |
0.376 |
|
| 1980 |
Sallan SE, Cronin C, Zelen M, Zinberg NE. Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine New England Journal of Medicine. 302: 135-138. PMID 6985702 DOI: 10.1056/Nejm198001173020302 |
0.302 |
|
| 1979 |
Zelen M. A new design for randomized clinical trials New England Journal of Medicine. 300: 1242-1245. PMID 431682 DOI: 10.1056/Nejm197905313002203 |
0.314 |
|
| 1978 |
Rozencweig M, Zelen M, Von Hoff DD, Muggia FM. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer? New England Journal of Medicine. 299: 1363-1364. PMID 581394 DOI: 10.1056/Nejm197812142992411 |
0.323 |
|
| 1975 |
Fisher B, Carbone P, Economou SG, Frelick R, Glass A, Lerner H, Redmond C, Zelen M, Band P, Katrych DL, Wolmark N, Fisher ER. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. The New England Journal of Medicine. 292: 117-122. PMID 1105174 DOI: 10.1056/Nejm197501162920301 |
0.32 |
|
| 1974 |
Zelen M. The randomization and stratification of patients to clinical trials Journal of Chronic Diseases. 27: 365-375. PMID 4612056 DOI: 10.1016/0021-9681(74)90015-0 |
0.307 |
|
| 1969 |
Zelen M, Feinleib M. On the theory of screening for chronic diseases Biometrika. 56: 601-614. DOI: 10.1093/Biomet/56.3.601 |
0.356 |
|
| 1966 |
Myers MH, Axtell LM, Zelen M. The use of prognostic factors in predicting survival for breast cancer patients Journal of Chronic Diseases. 19: 923-933. PMID 5967277 DOI: 10.1016/0021-9681(66)90008-7 |
0.325 |
|
| Show low-probability matches. |